Cancer-associated fibroblasts: The chief architect in the tumor microenvironment

Stromal heterogeneity of tumor microenvironment (TME) plays a crucial role in malignancy and therapeutic resistance. Cancer-associated fibroblasts (CAFs) are one of the major players in tumor stroma. The heterogeneous sources of origin and subsequent impacts of crosstalk with breast cancer cells flaunt serious challenges before current therapies to cure triple-negative breast cancer (TNBC) and other cancers. The positive and reciprocal feedback of CAFs to induce cancer cells dictates their mutual synergy in establishing malignancy. Their substantial role in creating a tumor-promoting niche has reduced the efficacy of several anti-cancer treatments, including radiation, chemotherapy, immunotherapy, and endocrine therapy. Over the years, there has been an emphasis on understanding CAF-induced therapeutic resistance in order to enhance cancer therapy results. CAFs, in the majority of cases, employ crosstalk, stromal management, and other strategies to generate resilience in surrounding tumor cells. This emphasizes the significance of developing novel strategies that target particular tumor-promoting CAF subpopulations, which will improve treatment sensitivity and impede tumor growth. In this review, we discuss the current understanding of the origin and heterogeneity of CAFs, their role in tumor progression, and altering the tumor response to therapeutic agents in breast cancer. In addition, we also discuss the potential and possible approaches for CAF-mediated therapies.

• Publication year

  2023

• Venue

  Frontiers in Cell and Developmental Biology

• Publication date

  2023-01-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3389/fcell.2023.1089068PMID 36793444PMCID 9923123
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD146+ Pericytes Subset Isolated from Human Micro-Fragmented Fat Tissue Display a Strong Interaction with Endothelial Cells: A Potential Cell Target for Therapeutic Angiogenesis

  2022cited by this paper
• Dll1-mediated Notch signaling drives tumor cell crosstalk with cancer associated fibroblasts to promote radioresistance in breast cancer.

  2022influential reference
• Targeting Cancer-Associated Fibroblasts in the Bone Marrow Prevents Resistance to CART-Cell Therapy in Multiple Myeloma.

  2022cited by this paper
• CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian Cancer

  2022cited by this paper
• Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL-6 Mediated Therapy Resistance in Pancreatic Cancer.

  2022cited by this paper
• Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets

  2022cited by this paper
• Tumor Vasculature

  2021cited by this paper
• Metabolic pathways fuelling protumourigenic cancer-associated fibroblast functions

  2021cited by this paper
• Cancer‐Associated Fibroblast‐Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression

  2021cited by this paper
• Abstract 117: Inhibition of Hedgehog signaling alters fibroblast composition in pancreatic cancer

  2021cited by this paper
• Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy

  2021influential reference
• The Role of Cancer-Associated Fibroblast as a Dynamic Player in Mediating Cancer Stemness in the Tumor Microenvironment

  2021cited by this paper
• The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis

  2021cited by this paper
• Cancer associated-fibroblast-derived exosomes in cancer progression

  2021cited by this paper
• Type I collagen deletion in α SMA + myofibroblasts enhances immune suppression and accelerates progression of pancreatic cancer

  2021cited by this paper
• CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion

  2021cited by this paper
• Targeted Therapy Modulates the Secretome of Cancer-Associated Fibroblasts to Induce Resistance in HER2-Positive Breast Cancer

  2021cited by this paper
• Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy

  2021cited by this paper
• Role of cancer‐associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer

  2021cited by this paper
• Cancer-associated fibroblasts-derived exosomes upregulate microRNA-135b-5p to promote colorectal cancer cell growth and angiogenesis by inhibiting thioredoxin-interacting protein.

  2021cited by this paper
• Cancer-associated fibroblasts: overview, progress, challenges, and directions

  2021cited by this paper
• Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity

  2021cited by this paper
• Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

  2021cited by this paper
• Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer

  2021cited by this paper
• Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer

  2021influential reference
• Carcinoma-associated fibroblasts derived exosomes modulate breast cancer cell stemness through exonic circHIF1A by miR-580-5p in hypoxic stress

  2021cited by this paper
• JAK2 regulates paclitaxel resistance in triple negative breast cancers

  2021cited by this paper
• Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer.

  2021cited by this paper
• Clinical Translation of Neutrophil Imaging and Its Role in Cancer

  2021cited by this paper
• Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy

  2021cited by this paper
• Prognostic significance of PD-L1-positive cancer-associated fibroblasts in patients with triple-negative breast cancer

  2021cited by this paper
• Determinants and Functions of CAFs Secretome During Cancer Progression and Therapy

  2021cited by this paper
• Cancer-Associated Fibroblast Subpopulations With Diverse and Dynamic Roles in the Tumor Microenvironment

  2021cited by this paper
• Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.

  2021cited by this paper
• The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts

  2020cited by this paper
• miR-210 Transferred by Lung Cancer Cell Derived Exosomes May Act as Proangiogenic Factor in Cancer-associated Fibroblasts by Modulating JAK2/STAT3 Pathway.

  2020cited by this paper
• Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer.

  2020cited by this paper
• Autophagy modulation altered differentiation capacity of CD146+ cells toward endothelial cells, pericytes, and cardiomyocytes

  2020cited by this paper
• Neutrophils in the Tumor Microenvironment.

  2020cited by this paper
• Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade

  2020cited by this paper
• Cancer associated fibroblasts-derived exosomes contribute to radioresistance through promoting colorectal cancer stem cells phenotype.

  2020cited by this paper
• miR-9-Mediated Inhibition of EFEMP1 Contributes to the Acquisition of Pro-Tumoral Properties in Normal Fibroblasts

  2020cited by this paper
• Epigenetic Reprogramming of Cancer-Associated Fibroblasts Deregulates Glucose Metabolism and Facilitates Progression of Breast Cancer.

  2020cited by this paper
• Periostin+cancer‐associated fibroblasts promote lymph node metastasis by impairing the lymphatic endothelial barriers in cervical squamous cell carcinoma

  2020cited by this paper
• T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting

  2020influential reference
• The Pancreatic Tumor Microenvironment Compensates for Loss of GOT2

  2020cited by this paper
• Fibroblast subtypes define a metastatic matrisome in breast cancer.

  2020influential reference
• The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome

  2020cited by this paper
• A framework for advancing our understanding of cancer-associated fibroblasts

  2020cited by this paper
• Acquired radioresistance in cancer associated fibroblasts is concomitant with enhanced antioxidant potential and DNA repair capacity

  2020cited by this paper
• YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression

  2020cited by this paper
• Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome

  2020influential reference
• Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma

  2020cited by this paper
• Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma

  2020cited by this paper
• Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion

  2020cited by this paper
• Deconstructing tumor heterogeneity: the stromal perspective

  2020influential reference
• Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins.

  2020cited by this paper
• SULF1 suppresses Wnt3A-driven growth of bone metastatic prostate cancer in perlecan-modified 3D cancer-stroma-macrophage triculture models

  2020cited by this paper
• Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma

  2020cited by this paper
• Tumor-Reprogrammed Stromal BCAT1 Fuels Branched Chain Ketoacid Dependency in Stromal-Rich PDAC Tumors

  2020cited by this paper
• Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche

  2020cited by this paper
• Progesterone and breast cancer.

  2020cited by this paper
• Single cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma.

  2020cited by this paper
• Molecular principles of metastasis: a hallmark of cancer revisited

  2020cited by this paper
• Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma

  2020cited by this paper
• Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways

  2020cited by this paper
• High stromal nicotinamide N‐methyltransferase (NNMT) indicates poor prognosis in colorectal cancer

  2020cited by this paper
• The role of collagen in cancer: from bench to bedside

  2019cited by this paper
• Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer

  2019cited by this paper
• The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions

  2019cited by this paper
• FGF2 induces breast cancer growth through ligand‐independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences

  2019cited by this paper
• Cancer associated fibroblasts: is the force the path to the dark side?

  2019cited by this paper
• Targeting Cancer Associated Fibroblasts in the Bone Marrow Prevents Resistance to Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma

  2019cited by this paper
• Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy

  2019cited by this paper
• Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts

  2019cited by this paper
• The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment

  2019cited by this paper
• Dual CTLA-4 and PD-L1 Blockade Inhibits Tumor Growth and Liver Metastasis in a Highly Aggressive Orthotopic Mouse Model of Colon Cancer

  2019cited by this paper
• Dualism of FGF and TGF-β Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant

  2019cited by this paper
• A Stromal Lysolipid-Autotaxin Signaling Axis Promotes Pancreatic Tumor Progression.

  2019cited by this paper
• COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer

  2019cited by this paper
• Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs

  2019cited by this paper
• Crosstalk between cancer‐associated fibroblasts and immune cells in cancer

  2019cited by this paper
• Cancer-associated fibroblasts produce Netrin-1 to control cancer cell plasticity.

  2019cited by this paper
• Integrins, CAFs and Mechanical Forces in the Progression of Cancer

  2019cited by this paper
• CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer

  2019cited by this paper
• Integrins as biomechanical sensors of the microenvironment

  2019cited by this paper
• Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer‐associated fibroblasts

  2019influential reference
• CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer.

  2019cited by this paper
• Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts

  2019cited by this paper
• Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts.

  2019cited by this paper
• CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinoma.

  2019cited by this paper
• Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy

  2019cited by this paper
• Macrophage-secreted TGF-β1 contributes to fibroblast activation and ureteral stricture after ablation injury.

  2019cited by this paper
• Proteomics reveals NNMT as a master metabolic regulator of cancer associated fibroblasts

  2019cited by this paper
• Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression

  2019cited by this paper
• Role of Exosomes in Crosstalk Between Cancer-Associated Fibroblasts and Cancer Cells

  2019cited by this paper
• Tumor angiogenesis: causes, consequences, challenges and opportunities

  2019cited by this paper
• Deep Learning With Sampling in Colon Cancer Histology

  2019cited by this paper
• Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance

  2019influential reference
• Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy.

  2019cited by this paper

• GLRX5 is a prognostic marker in bladder cancer and correlates with activation of cancer-associated fibroblasts in the tumor microenvironment.

  2026cites this paper
• Distinctive features of cancer-associated fibroblasts expressing CD105, a novel biomarker for bone metastasis, in early-stage invasive ductal breast cancer.

  2026cites this paper
• Metabolic crosstalk among cancer-associated fibroblasts, adipocytes and immune cells as an immunosuppressive tumor microenvironment driver.

  2026cites this paper
• Characterizing tumor microenvironment heterogeneity in EBV+ nTNKL vs ENKTL using spatial transcriptomics and MIF.

  2026cites this paper
• РОЛЬ ER+-ФІБРОБЛАСТІВ У ФОРМУВАННІ АГРЕСИВНОГО ФЕНОТИПУ ЕНДОМЕТРІОЇДНОЇ КАРЦИНОМИ ЕНДОМЕТРІЮ

  2026cites this paper
• The Role of Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in the Tumor Microenvironment and Their Impact on Ovarian Cancer Survival and Therapy

  2026cites this paper
• Lactylation in cancer: molecular mechanisms and advances in clinical study

  2026cites this paper
• Identifying Therapeutic Targets for Triple-Negative Breast Cancer using a Novel Mathematical Model of the Tumor Microenvironment

  2026cites this paper
• Advances in natural compounds modulating autophagy for the therapeutic intervention of heart failure.

  2026cites this paper
• Histologic Categorization of Desmoplastic Reaction in Triple-Negative Breast Cancer: Its Relevance to Neoadjuvant Chemoimmunotherapy Response and Tumor Biology.

  2025cites this paper
• The design of the spheroids-based in vitro tumor model determines its biomimetic properties.

  2025cites this paper
• Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition

  2025cites this paper
• Epithelium-derived exosomal dipeptidyl peptidase-4 involved in arecoline-induced oral submucous fibrosis.

  2025cites this paper
• Structural insights into antibody-based immunotherapy for hepatocellular carcinoma

  2025cites this paper
• pH of Microenvironment Directly Modulates the Phenotype and Function of Cancer-Associated Fibroblasts

  2025cites this paper
• E2F1 activates breast stromal fibroblasts and promotes their paracrine pro-carcinogenic effects

  2025cites this paper
• Extracellular vesicles and microRNAs in cancer progression.

  2025cites this paper
• Tiny messengers, big Impact: Exosomes driving EMT in oral cancer.

  2025cites this paper
• For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy

  2025cites this paper
• Nano-drug delivery strategies affecting cancer-associated fibroblasts to reduce tumor metastasis

  2025cites this paper
• Ex.50.T aptamer impairs tumor–stroma cross-talk in breast cancer by targeting gremlin-1

  2025cites this paper
• Microenvironment-based immunotherapy in oral cancer: a comprehensive review

  2025cites this paper
• The role of CAFs in therapeutic resistance in triple negative breast cancer: an emerging challenge

  2025cites this paper
• The role of immunotherapy in targeting tumor microenvironment in genitourinary cancers

  2025cites this paper
• Cholesterol effects on the tumor immune microenvironment: from fundamental concepts to mechanisms and implications

  2025cites this paper
• Innovative nanoparticle strategies for treating oral cancers

  2025cites this paper
• Enhancing detection and monitoring of circulating tumor cells: Integrative approaches in liquid biopsy advances

  2025cites this paper
• Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements

  2025cites this paper
• The Metabolic Landscape of Cancer Stem Cells: Insights and Implications for Therapy

  2025cites this paper
• Identification and validation of SAC3D1 as a prognostic biomarker promoting the development of osteosarcoma

  2025cites this paper
• Exosomes in inflammation and cancer: from bench to bedside applications

  2025cites this paper
• The Role of Tumor Microenvironment and Immune Cell Crosstalk in Triple-Negative Breast Cancer (TNBC): Emerging Therapeutic Opportunities.

  2025cites this paper
• Single-Cell Transcriptomic Analysis Unveils Key Regulators and Signaling Pathways in Lung Adenocarcinoma Progression

  2025cites this paper
• Aurantio-obtusin modulates Wilms Tumour 1 within the breast tumour microenvironment reducing immunosuppression and tumour growth

  2025cites this paper
• Cancer-associated fibroblasts in cancer drug resistance and cancer progression: a review

  2025cites this paper
• Development of tetraculture spheroids as a versatile 3D model for personalized breast cancer research

  2025cites this paper
• Deciphering the tumor ecosystem dynamics undergoing immunochemotherapy therapy across multiple cancer types unveils the immunosuppressive role of S100A4 in fibroblasts by promoting PD-L1 expression in tumor cells

  2025cites this paper
• Cancer-Associated Fibroblasts: Immunosuppressive Crosstalk with Tumor-Infiltrating Immune Cells and Implications for Therapeutic Resistance

  2025cites this paper
• Lymphoid stroma in all its states

  2025cites this paper
• Role of monocarboxylate transporters in cancer immunology and their therapeutic potential

  2025cites this paper
• Cancer-associated fibroblasts in human malignancies, with a particular emphasis on sarcomas (Review)

  2025influential citation
• In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy

  2025cites this paper
• The Role of Tumor Microenvironment in Triple-Negative Breast Cancer and Its Therapeutic Targeting

  2025cites this paper
• Cancer-associated fibroblasts as a potential therapeutic target for thyroid cancers

  2025cites this paper
• Cancer-Associated Fibroblasts in Solid Tumors and Sarcomas: Heterogeneity, Function, and Therapeutic Implications

  2025cites this paper
• Downregulated of CTGF reveals mechanism, remodels immune microenvironment, modulates drug sensitivity in bladder cancer

  2025cites this paper
• The Duality of Collagens in Metastases of Solid Tumors

  2025cites this paper
• Biophysical Properties of the Extracellular Matrix in Cancer: Insights Into Immunotherapy.

  2025cites this paper
• Immune snapshots along the inflammation-to-cancer road in bladder urothelium

  2025cites this paper
• Strategies for Pancreatic Cancer-Responsive Nanodrug Platforms Targeting Tumor Hypoxic Environments

  2025cites this paper
• Innovative gene targeted treatments for osteosarcoma: a mini review of current clinical evidence and future prospects

  2025cites this paper
• UGP2 is a potential target for breast cancer, based on bioinformatics analysis and in vitro experiments

  2025cites this paper
• Mucosal Melanoma: Mechanisms of Its Etiology, Progression, Resistance and Therapy

  2025cites this paper
• Targeting cancer stem cell plasticity and tumor microenvironment crosstalk: a comprehensive review

  2025cites this paper
• Hepatic Fibrosis and Liver Cancer

  2025cites this paper
• Bibliometric analysis on the correlation between colorectal cancer and tumor microenvironment [2009–2024]

  2025cites this paper
• Genetic-bioengineering of nanotechnology in cell-specific pharmaceutical targeting: Biological, pharmacological, and biochemical impact of nanomaterials-based breast cancer therapies

  2024cites this paper
• FGFR-related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review)

  2024cites this paper
• Dissecting the roles of exosomal cancer-associated fibroblasts-derived non-coding RNAs in tumor progression: A complete guide.

  2024cites this paper
• From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies

  2024cites this paper
• Exosomal misfolded proteins released by cancer stem cells: dual functions in balancing protein homeostasis and orchestrating tumor progression

  2024cites this paper
• RANK in cancer-associated fibroblasts: A valuable prognostic determinant for metastasis in early-stage breast cancer patients

  2024cites this paper
• Unlocking the tumor-immune microenvironment in osteosarcoma: insights into the immune landscape and mechanisms

  2024cites this paper
• Tumor Cell Communications as Promising Supramolecular Targets for Cancer Chemotherapy: A Possible Strategy

  2024cites this paper
• Improving efficacy of TNBC immunotherapy: based on analysis and subtyping of immune microenvironment

  2024cites this paper
• Podoplanin Expression in Early-Stage Colorectal Cancer-Associated Fibroblasts and Its Utility as a Diagnostic Marker for Colorectal Lesions

  2024cites this paper
• The key role of matrix stiffness in colorectal cancer immunotherapy: Mechanisms and therapeutic strategies.

  2024cites this paper
• CD8+ T-cell exhaustion: Impediment to triple-negative breast cancer (TNBC) immunotherapy.

  2024cites this paper
• Deciphering the landscape of triple negative breast cancer from microenvironment dynamics and molecular insights to biomarker analysis and therapeutic modalities

  2024cites this paper
• Adipose-Derived Stromal Cells and Cancer-Associated Fibroblasts: Interactions and Implications in Tumor Progression

  2024cites this paper
• Unveiling immune cell response disparities in human primary cancer-associated fibroblasts between two- and three-dimensional cultures

  2024cites this paper
• Targeting glutamine metabolism crosstalk with tumor immune response.

  2024cites this paper
• Development of a cancer metastasis-on-chip assay for high throughput drug screening

  2024cites this paper
• Microfluidic-based human prostate-cancer-on-chip

  2024cites this paper
• The Metabolic Syndrome, a Human Disease

  2024cites this paper
• Intercellular crosstalk between cancer cells and cancer-associated fibroblasts via exosomes in gastrointestinal tumors

  2024cites this paper
• Dynamic interactions in the tumor niche: how the cross-talk between CAFs and the tumor microenvironment impacts resistance to therapy

  2024cites this paper
• Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy.

  2024cites this paper
• The movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria

  2024cites this paper
• Cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production

  2024cites this paper
• Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor–stroma ratio in colon cancer

  2024cites this paper
• Unraveling the Tumor Microenvironment: Insights into Cancer Metastasis and Therapeutic Strategies.

  2024cites this paper
• The Tumor Stroma of Squamous Cell Carcinoma: A Complex Environment That Fuels Cancer Progression

  2024cites this paper
• 3D Cell Migration Chip (3DCM‐Chip): A New Tool toward the Modeling of 3D Cellular Complex Systems

  2024cites this paper
• The multifaceted role of extracellular vesicles (EVs) in colorectal cancer: metastasis, immune suppression, therapy resistance, and autophagy crosstalk

  2024cites this paper
• Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling.

  2024cites this paper
• Unraveling the intricacies of cancer‐associated fibroblasts: a comprehensive review on metabolic reprogramming and tumor microenvironment crosstalk

  2024cites this paper
• Prognostic Value of Cancer-Associated Fibroblast Marker Expression in the Intratumoral and Marginal Areas of Soft Tissue Sarcoma

  2024cites this paper
• HIPK2 in Colon Cancer: A Potential Biomarker for Tumor Progression and Response to Therapies

  2024cites this paper
• Reprogramming of normal fibroblasts into ovarian cancer-associated fibroblasts via non-vesicular paracrine signaling induces an activated fibroblast phenotype.

  2024cites this paper
• Extracellular RNA in oncogenesis, metastasis and drug resistance

  2024cites this paper
• Evolving immunotherapeutic solutions for triple-negative breast carcinoma.

  2024cites this paper
• CD248‐expressing cancer‐associated fibroblasts induce non‐small cell lung cancer metastasis via Hippo pathway‐mediated extracellular matrix stiffness

  2024cites this paper
• Tumoroids, a valid preclinical screening platform for monitoring cancer angiogenesis

  2024cites this paper
• Analysis of Immune Resistance Mechanisms in TNBC: Dual Effects Inside and Outside the Tumor.

  2023cites this paper
• Normal Uterine Fibroblast Are Reprogramed into Ovarian Cancer-Associated Fibroblasts by Ovarian Tumor-derived Conditioned Media

  2023cites this paper
• Toward a Unifying Hypothesis for Redesigned Lipid Catabolism as a Clinical Target in Advanced, Treatment-Resistant Carcinomas

  2023cites this paper
• The role of cancer-associated fibroblasts in bladder cancer progression

  2023cites this paper
• CD105 expression in cancer-associated fibroblasts: a biomarker for bone metastasis in early invasive ductal breast cancer patients

  2023influential citation
• Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer

  2023cites this paper